An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus
Abstract Hydroxychloroquine (HCQ) use is indicated for patients with systemic lupus erythematosus (SLE). Nevertheless, reports discussing the reasons for not prescribing HCQ are limited. We identified the factors that interfere with HCQ use in patients with SLE. This observational, single-center stu...
Main Authors: | Atsushi Manabe, Ryuichi Minoda Sada, Hirofumi Miyake, Hiroyuki Akebo, Yukio Tsugihashi, Kazuhiro Hatta |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-04-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-58463-3 |
Similar Items
-
New onset bullous lupus erythematosus in a systemic lupus erythematosus patient after initiation of hydroxychloroquin
by: Chanchal Gera, et al.
Published: (2014-01-01) -
Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
by: Noël Zahr, et al.
Published: (2021-03-01) -
New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre
by: Rahana Abd Rahman, et al.
Published: (2020-12-01) -
A case of lupus erythematosus panniculitis misdiagnosed as vasculitis
by: Yuqi TANG, et al.
Published: (2023-04-01) -
A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature
by: Daniel Kwak, et al.
Published: (2020-09-01)